SNP it all together

Genomics plc mines 2+ million genotypes and phenotypes to de-risk drug discovery

Genomewide association studies can link SNPs to specific disease phenotypes, but the narrow scope of individual SNP studies limits their power of prediction for targeting the associated genes. Genomics plc is developing a computational platform that integrates disparate sets of genomic and phenotypic data to predict the good and bad outcomes of a compound's on-target effects.

The company has "the largest database of its kind that links genetic variation with

Read the full 696 word article

How to gain access

Continue reading with a
two-week free trial.